Showing results (181-190 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|January 31, 2004
The health economics of bladder cancer: a comprehensive review of the published literatureMarc F Botteman, Chris L Pashos, Alberto Redaelli, et al.Pharmacoeconomics|January 15, 2004
Cost-effective strategies in the prevention of diabetic nephropathyJonathan D Rippin, Anthony H Barnett, Stephen C BainPharmacoeconomics|January 21, 2004
Health economic evaluation of non-melanoma skin cancer and actinic keratosisMitchell K Higashi, David L Veenstra, Paul C LangleyPharmacoeconomics|October 9, 2019
Transparency in Health Economic Modeling: Options, Issues and Potential SolutionsEric Q Wu, Zheng-Yi Zhou, Jipan Xie, et al.Pharmacoeconomics|September 1, 2018
Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in GermanyKatharina Kähm, Michael Laxy, Udo Schneider, et al.Pharmacoeconomics|August 29, 2018
Estimating Informal Caregiving Time from Patient EQ-5D Data: The Informal CARE Effect (iCARE) ToolMaria Gheorghe, Renske J Hoefman, Matthijs M Versteegh, et al.Pharmacoeconomics|May 21, 2018
Discounting in Economic EvaluationsArthur E Attema, Werner B F Brouwer, Karl ClaxtonPharmacoeconomics|April 30, 2017
Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its CharacteristicsLiz Morrell, Sarah Wordsworth, Sian Rees, et al.Pharmacoeconomics|May 5, 2018
Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO)Hui Shao, Vivian Fonseca, Charles Stoecker, et al.Pharmacoeconomics|May 9, 2018
Smoking Cessation: A Comparison of Two Model StructuresBecky Pennington, Alex Filby, Lesley Owen, et al.Pageof 335